As genomic studies become larger and more diverse, sample collection can make or break their success. Discover why collection ...
BioLife has been granted a US patent for its effervescent OralMatrix oral peptide delivery platform, with preclinical data ...
A large real-world study published in Nature Medicine demonstrates that whole-genome sequencing can identify actionable ...
What happens when the cellular machinery making therapeutic proteins slows down? New research in Nature shows why translation ...
UK genomics and drug discovery company OutSee has received £50,000 in Innovate UK funding to develop an agentic AI sub-system ...
An experimental synthetic non-coding RNA drug has reversed signs of systemic sclerosis in patient-derived immune cells and mouse models, with researchers now preparing an IND application to the FDA.
Whole-genome sequencing of parasites from Ugandan patients has uncovered a cluster of genetic variants linked to reduced ...
A £20 million high-security facility in Liverpool is set to accelerate drug and vaccine discovery by integrating artificial ...
A new NIH-funded study suggests the GLP-1 receptor agonist semaglutide may slow biological ageing and extend lifespan in ...
A compound originally designed to block a cancer-associated protein has demonstrated unexpected benefits for bone health and ...
The global oligonucleotide CDMO market is projected to nearly triple in value to USD 11.14 billion by 2031, driven by rising ...
A structure-guided peptide vaccine targeting PCSK9 has reduced LDL cholesterol and atherosclerotic plaque burden in mouse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results